GYA01 (CART84)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GYA01 (CART84), covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL). [Phase 1, Phase 2]